Related Experiment Video
Updated: Apr 20, 2026

08:16
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
19.5K
Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis
Edoardo Micotti1, Alessandra Paladini1, Claudia Balducci1
1Neuroscience Department, IRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Italy.
Neurobiology of Aging
|December 1, 2014
Summary
This study identified common Alzheimer's disease biomarkers in transgenic mice and humans using advanced MRI. These findings support MRI as a translational tool for preclinical therapeutic development.
Area of Science:
- Neuroscience
- Biomedical Imaging
- Genetics
Background:
- Alzheimer's disease (AD) research relies on animal models.
- Transgenic (Tg) mice overexpressing mutated human genes are crucial for modeling AD pathology.
- Comparing different Tg mouse models is essential for identifying reliable biomarkers.
Purpose of the Study:
- To systematically compare double (TASTPM) and triple (APP/PS2/Tau) Tg mice models of Alzheimer's disease.
- To identify homologous biomarkers between mouse models and human AD patients using serial MRI and spectroscopy.
- To evaluate the translational potential of MRI as a preclinical research tool.
Main Methods:
- Serial magnetic resonance imaging (MRI) and spectroscopy were performed on TASTPM and APP/PS2/Tau Tg mice from 4 to 26 months of age.
- Wild-type (WT) mice served as controls.
- Analysis focused on brain structure (hippocampal atrophy, entorhinal cortex thinning, striatal atrophy) and neurochemical changes (glutamate, myo-inositol).
Main Results:
- Both Tg mouse models exhibited hippocampal atrophy compared to WT mice.
- APP/PS2/Tau mice showed age-dependent atrophy, while TASTPM mice displayed it from the earliest time point.
- Common findings included age-related entorhinal cortex thinning, striatal atrophy, and synaptophysin loss. Lower glutamate and increased myo-inositol were observed in specific Tg models.
- MRI revealed homologous biomarkers between Tg mice and human AD patients.
Conclusions:
- Noninvasive MRI analysis identified common biomarkers for Alzheimer's disease in Tg mice and humans.
- The study highlights the translational potential of MRI for preclinical investigations of AD therapeutics.
- TASTPM and APP/PS2/Tau Tg mice offer valuable models for studying AD pathogenesis and evaluating treatments.

